Graphite Bio Competitors and Similar CompaniesClear all
Asklepios BioPharmaceutical's competitors and similar companies include Ambrx and Precigen.
 Asklepios BioPharmaceutical Asklepios BioPharmaceutical is engaged in the development and delivery of novel protein. |  Ambrx Ambrx is a biopharmaceutical company that discovers and develops engineered precision biologics therapeutics using an expanded genetic code. |  Precigen Precigen (formerly known as Intrexon) is a biopharmaceutical company developing gene and cellular therapies for immuno-oncology, autoimmune, and infectious diseases. | |
Founding Date | Founding Date 2001 | Founding Date 2003 | Founding Date 1998 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Chapel Hill, US HQ Roslin, GB | Locations San Diego, US HQ | Locations Germantown, US HQ Gent, BE Sioux Center, US |
Employees | Employees 5172% increase | Employees 70 | Employees 601 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1.8 b | Valuation ($) 246.6 m |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $7.4m (FY, 2022) | Revenue (est.) $9.7m (FY, 2025) |
Net income | Net income N/A | Net income ($78m) (FY, 2022) | Net income ($250.6m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 235m | Total funding raised $ 347.9m | Total funding raised $ 379m |
For sources of this data, please see the company profile
View Company Profiles
Ambrx
HQ
San Diego, US
Employees
70
Ambrx is a biopharmaceutical company that discovers and develops engineered precision biologics therapeutics using an expanded genetic code.
View companyPrecigen
HQ
Germantown, US
Employees
601
Precigen (formerly known as Intrexon) is a biopharmaceutical company developing gene and cellular therapies for immuno-oncology, autoimmune, and infectious diseases.
View company